Pharmaceutical pricing practices, competition law and parallel trade - SMi' Parallel Trade Conference

Parallel Trade Conference
Flemming Wagner, CEO of ABACUS MEDICINE A/S has confirmed to speak at the SMi's Parallel Trade Conference this February www.parallel-trade.com/ein
His presentation will be dedicated to Pharmaceutical pricing practices, competition law and parallel trade: What do recent antitrust abuses by pharmaceutical companies mean for parallel trade?
• Overview of key recent cases in UK and EC
• Main issues
• Regulatory context in which these have occurred
• What are the implications of these cases for parallel trade
Bristows - a law firm serving innovative companies and industry leaders around the world will be hosting an interactive workshop during the Parallel Trade Conference (8th February) on EU legal issues to be aware of in the context of parallel trade of pharmaceuticals. This workshop aims to address the issues that the pharmaceutical industry faces in protecting its IP rights and its distribution strategies whilst at the same time remaining on the right side of competition law; as well as exploring the regulatory requirements that the parallel traders will have to comply with.
More topics in discussion at the ONLY event on Parallel Trade!
Visit our website to view the programme and book your place
www.parallel-trade.com/ein
To sponsor or exhibit, contact Alia Malick on +44 (0)20 7827 6168
For delegate and group bookings contact Fateja Begum on +44 (0)20 7827 6184
Follow 'SMi Pharma' on LinkedIn and @SMIpharm on Twitter for latest pharmaceutical industry updates.
* Parallel trade in pharmaceuticals: firm responses and competition policy, Margaret K. Kyle
SMi's Parallel Trade Conference | 6- 7th February 2018 | London, UK
www.parallel-trade.com/ein
Lyudmyla Durneva
SMi Group
+44 (0) 207 827 6088
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.